NexgenRx Inc.
NEGXF
$0.33
$0.0622.04%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.33% | 14.86% | |||
| Total Other Revenue | 123.23% | -211.31% | |||
| Total Revenue | 13.37% | -5.42% | |||
| Cost of Revenue | 43.44% | -32.84% | |||
| Gross Profit | 9.35% | 0.04% | |||
| SG&A Expenses | -3.92% | -2.41% | |||
| Depreciation & Amortization | -14.26% | -14.33% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.01% | -9.16% | |||
| Operating Income | 70.33% | 19.22% | |||
| Income Before Tax | 126.44% | -7.00% | |||
| Income Tax Expenses | -103.20% | 3,186.75% | |||
| Earnings from Continuing Operations | 781.03% | -130.29% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 781.03% | -130.29% | |||
| EBIT | 70.33% | 19.22% | |||
| EBITDA | 65.40% | -15.38% | |||
| EPS Basic | 478.13% | -153.33% | |||
| Normalized Basic EPS | 72.73% | 22.22% | |||
| EPS Diluted | 459.38% | -162.75% | |||
| Normalized Diluted EPS | 59.09% | 41.94% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 8.34% | -15.59% | |||
| Dividend Per Share | -- | 0.00% | |||
| Payout Ratio | 1.01% | -5.09% | |||